Tender detail

Molecular genetic tests from blood

Summary

The tender concerns molecular genetic tests from blood for use in genetic diagnostics and risk assessment. The bidder must submit a compliant offer, provide the required contact details, confirm that the offer meets the tender documents, and use the required price structure and form. The laboratory must be accredited to EVS-EN ISO 15189:2017, and the bidder must provide the accreditation certificate and the laboratory website address. The notice also includes mandatory exclusion grounds and a sanctions-related declaration on subcontractors and suppliers.

Reference number
309282-0000
Buyer
Aktsiaselts Ida-Tallinna Keskhaigla
Country
Estonia (EST)
Procedure
Social and other specific services procedure
CPV
85145000 Services provided by medical laboratories
Deadline
2026-05-14
Status
Open
Contract subject
Services
Estimated value
880 000 EUR
Source
RHR

Participation requirements

Tender requirements are available in the official tender documents.

Compliance requirements

The bidder and its management bodies must not have been finally convicted within the last five years for participation in a criminal organisation, corruption or fraud. If such a ground applies, it must also be checked whether the exclusion period is still in force. The bidder may, where relevant, submit evidence of self-cleaning measures to restore reliability. The machine-readable notice did not include any other precise exclusion grounds; these must be checked in the tender documents.

Qualification criteria and exclusion grounds

The bidder’s laboratory must be accredited according to EVS-EN ISO 15189:2017, Medical laboratories — Requirements for quality and competence. The bid must include the accreditation certificate. The laboratory’s public website must provide information on the currently available tests, including sample material requirements and health insurance codes for each test. For the polygenic analysis panel, the website must publish the list of genes analysed and keep it updated in line with new genetic associations, including treatment options. The bidder must provide the website address. The machine-readable notice did not include any other precise qualification or suitability requirements; these must be checked in the tender documents.